Effectiveness of Tocilizumab in the Treatment of a Recent Kidney Transplant Recipient With COVID-19

• Published in: Curēus (Palo Alto, CA) Vol. 16; no. 1; p. e53163
• Main Authors: Chikobava, Elisabed, Chkhikvadze, Lasha, Menabde, Keti, Pkhakadze, Giorgi, Tchokhonelidze, Irma
• Format: Journal Article
• Language: English
• Published: United States Springer Nature B.V 29.01.2024; Cureus
• Subjects: Allergy/Immunology; Antibiotics; Antibodies; Blood; Clinical deterioration; Coronaviruses; COVID-19; Creatinine; Cytokines; Hospitalization; Infections; Infectious Disease; Kidney transplants; Monoclonal antibodies; Nephrology; Neutrophils; Oxygen therapy; Pandemics; Patients; Pneumonia; Proteins; Severe acute respiratory syndrome; Urinalysis; Urine; Viral infections; Vital signs; interleukin 6; covid-19; immunosuppression; tocilizumab; kidney transplantation

The coronavirus disease 2019 (COVID)-19 pandemic significantly affected transplantation care strategies due to the heightened vulnerability of transplant recipients to severe illness. We present a unique case of a 31-year-old female with COVID-19 pneumonia following a recent kidney transplant manage...